These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 30707474)

  • 61. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
    Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
    Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
    Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
    Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
    Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
    Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel KMT2A-USO1 fusion gene-induced de novo secondary acute myeloid leukaemia in a patient initially diagnosed with acute promyelocytic leukaemia.
    Jin W; Chen L; Liu Y; Chen Q; Zhao M; Tan Y; Zhang W; Song H; Weng X; Mi J; Chen S; Chen Z; Li J; Wang K
    Br J Haematol; 2021 Jan; 192(1):e32-e36. PubMed ID: 33216970
    [No Abstract]   [Full Text] [Related]  

  • 65. Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis.
    Giusiano S; Formisano-Tréziny C; Benziane A; Maroc N; Picard C; Hermitte F; Taranger-Charpin C; Gabert J
    Int J Lab Hematol; 2010 Aug; 32(4):398-409. PubMed ID: 19930410
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inv(11)(q21q23); KMT2A-MAML2, a Recurrent Genetic Abnormality in T-Cell Therapy-related Acute Lymphoblastic Leukemia.
    Mariani RA; Silva M; Caparelli E; Jennings LJ; Yap KL; Leuer KM; Weinstein J; Gong S
    J Pediatr Hematol Oncol; 2020 May; 42(4):e258-e261. PubMed ID: 31343482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cytogenetic and FISH findings are complementary in childhood ALL].
    Haltrich I; Csóka M; Kovács G; Fekete G
    Magy Onkol; 2008 Sep; 52(3):283-91. PubMed ID: 18845499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Acute lymphoblastic leukemia with inv(11)(q21q23.3)/KMT2A::MAML2 fusion gene progressed to acute myeloid leukemia: a case report].
    Zhang Y; Ni JB; Zhang QJ; Hui S; Wang CF; Wang T
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):196. PubMed ID: 38604799
    [No Abstract]   [Full Text] [Related]  

  • 70. Novel MLL/KMT2A-MON2 fusion in a child with therapy-related acute myeloid leukemia after treatment for acute promyelocytic leukemia.
    Gong Y; Wang M; Shen H; Chen Y; Cen J; Yin X; Yao L
    Mol Carcinog; 2021 Nov; 60(11):721-725. PubMed ID: 34236108
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features.
    Ragusa D; Makarov EM; Britten O; Moralli D; Green CM; Tosi S
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1207. PubMed ID: 32721124
    [TBL] [Abstract][Full Text] [Related]  

  • 73. KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic Leukemia.
    de Matos RRC; Ferreira GM; Meyer C; Marschalek R; Larghero P; Ribeiro RC; Liehr T; Othman M; Bizarro MTSM; Sobral da Costa E; Land MGP; Abdelhay E; Binato R; Silva MLM
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):e719-e722. PubMed ID: 34966090
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
    Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23);
    Du J; Chisholm KM; Tsuchiya K; Leger K; Lee BM; Rutledge JC; Paschal CR; Summers C; Xu M
    Pediatr Dev Pathol; 2021; 24(4):378-382. PubMed ID: 33749383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients.
    Chen X; Wang F; Zhang Y; Wang M; Tian W; Teng W; Ma X; Guo L; Fang J; Zhang Y; Zhu P; Liu H
    Leuk Lymphoma; 2019 Apr; 60(4):1071-1078. PubMed ID: 30277115
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia.
    Woo HY; Kim DW; Park H; Seong KW; Koo HH; Kim SH
    J Korean Med Sci; 2005 Feb; 20(1):36-41. PubMed ID: 15716599
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
    Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of a Cryptic KMT2A/AFDN Gene Fusion [ins(6;11)(q27;q23q23)] in a Pediatric Patient with Newly Diagnosed Acute Myeloid Leukemia.
    Berg HE; Greipp PT; Baughn LB; Falcon CP; Jackson CC; Peterson JF
    Lab Med; 2022 Jul; 53(4):e95-e99. PubMed ID: 34894139
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Acute leukemia of infants and neonates].
    Eguchi M
    Rinsho Ketsueki; 2021; 62(8):1308-1318. PubMed ID: 34497221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.